Related Experiment Videos
Terminal uremia and arteriovenous fistula patency
Insights
Arteriovenous fistulas for hemodialysis show varied patency based on kidney disease etiology. Chronic glomerulonephritis patients experienced better fistula survival than those with chronic pyelonephritis.
Area of Science:
- Nephrology
- Vascular Surgery
Background:
- Arteriovenous fistulas are crucial for chronic hemodialysis access.
- Understanding factors influencing fistula patency is vital for patient outcomes.
Purpose of the Study:
- To investigate the relationship between the etiology of end-stage renal disease and arteriovenous fistula patency.
- To identify factors affecting fistula survival in hemodialysis patients.
Main Methods:
- Retrospective review of 125 arteriovenous fistulas used for chronic hemodialysis.
- Analysis of fistula patency and patient survival in relation to disease etiology.
Main Results:
- Significant differences in fistula patency were observed between patients with chronic glomerulonephritis (CGN) and chronic pyelonephritis (CPN).
- CGN patients required fewer fistulas (1.30) and had longer mean survival (20 months) compared to CPN patients (2.14 fistulas, 4 months survival).
- Higher blood pressure correlated with increased fistula patency.
Conclusions:
- Fistula survival is more closely linked to the cause of kidney failure and hemodialysis care than the fistula type.
- Anticoagulation and larger anastomoses are recommended for high-risk patients.
- Consideration for kidney transplantation should be prioritized for patients with increased fistula deterioration risk.
Abstract:
One hundred and twenty-five arteriovenous fistulas for chronic hemodialysis are reviewed and their patency is related to the etiology of terminal uremia and other factors. A significant difference was found between the patency of fistulas of patients with chronic glomerulonephritis (CGN) and those of patients with chronic pyelonephritis (CPN). The average number of A-V fistulas in the CGN group was 1.30, while in those with CPN, 2.14 fistulas per patient necessitated construction. A pattern similar to that of the CGN group was observed in a third group of patients, who had an unclear diagnosis. The average number of fistulas was the same, and the mean survival 20 months in both groups, compared with the four months mean survival in the CPN group. Higher blood pressure levels were observed in the groups with a higher patency rate. The survival of patients with A-V fistulas appears to be related more directly to the etiology of the terminal uremia and care taken during hemodialysis than to the type of vascular connection. Anticoagulation and larger anastomoses are advisable in patients with increased risk of fistula deterioration. These patients should be included in the transplantation priority list.